Aptean and CAS collaborate to offer CAS Biosequences content in GenomeQuest
February 12, 2019
Combining the CAS BiosequencesTM Module and the GQ-Pat database on a single platform delivers a unique, comprehensive “one-stop” search solution for biotechnology intellectual property
Alpharetta, GA (February 12th, 2019) - Aptean has partnered with CAS, a division of the American Chemical Society, to make CAS Biosequences content available on the GenomeQuest sequence search platform beginning in late March. Aptean GenomeQuest is an intellectual property (IP) sequence search tool that integrates the world's largest, most up-to-date IP sequence database with state-of-the-art sequence comparison algorithms for powerful patent sequence search and analysis. Adding the CAS Biosequences Module to the Aptean GenomeQuest platform provides an additional source of human-curated biosequence content disclosed in patents and journals, extending the comprehensiveness of biotechnology IP searches and providing efficiency for users by making both of these critical resources accessible through GenomeQuest’s powerful, user-friendly interface.
“Our customers were telling us that they often searched GenomeQuest GQ-Pat and CAS REGISTRYSM separately to get the most complete results – a time-consuming task with a lot of duplication of effort,” said Henk Heus, Business Leader of GenomeQuest for Aptean. “The ability to search these content collections together, apply GenomeQuest’s analyses to the results, and prepare a single report is something we’ve wanted for many years. We are proud to have partnered with our colleagues at CAS to meet this long-standing need in the IP search community.”
The addition of the CAS Biosequences Module to GenomeQuest will give users direct access to CAS’s broad, highly curated collection of sequences from both journal and patent publications. CAS’s expert scientific analysts have generated unique content that specifically indexes chemical modifications to biosequences. This curated content allows users to quickly identify novel sequences both in patent claims as well as research studies. GenomeQuest’s powerful, web-based interactive analysis will enable searchers to write Boolean queries combining different percent identities with bibliographic and text terms to search this powerful combination of content-rich databases. While users previously had to search and analyze data sources separately, combine the results, and then deduplicate them, they will now be able to simultaneously search and analyze these critical content collections expediting their workflow and delivering new insights.
“Providing comprehensive, highly curated data that advances scientific insight is top-of-mind at CAS. So is listening to our customers. That’s why we are pleased to partner with Aptean to provide the world’s most valuable biosequence collection not only within CAS REGISTRY, but also now on the GenomeQuest platform,” said Katherine Gibson, Chief Innovation Officer for CAS. “We look forward to our continued collaboration with the IP search community and with our colleagues at Aptean.”
CAS, a division of the American Chemical Society, partners with R&D organizations globally to provide actionable scientific insights that help them plan, innovate, protect their innovations, and predict how new markets and opportunities will evolve. Scientific researchers, patent professionals and business leaders around the world across commercial, academic and government sectors rely on our solutions and services to advise discovery and strategy. Leverage our unparalleled content, specialized technology, and unmatched human expertise to customize solutions that will give your organization an information advantage. With more than 110 years’ experience, no one knows more about scientific information than CAS. Learn more at www.cas.org.
CAS – Where Science and Strategy Converge
Aptean provides specific industries with purpose-built ERP, supply chain management and compliance solutions. In today’s fast-paced, highly competitive economy, organizations don’t have time to waste forcing homegrown software, spreadsheets and one-size-fits-all solutions to do things they were never designed to do. That’s why over 2,500 highly specialized organizations in more than 20 industries and 54 countries rely on Aptean to streamline their everyday operations. To learn how Aptean can help your organization stay at the forefront of your industry, visit www.aptean.com.